Yüklüyor......
Precision Medicines’ Impact on Orphan Drug Designation
The incentives provided under the Orphan Drug Act (ODA) have been credited for catalyzing the marketing approval of drugs for the treatment of rare diseases by the US Food and Drug Administration. Orphan drug designation, the granting of special status to drugs or biologics (“drugs”) for the treatme...
Kaydedildi:
| Yayımlandı: | Clin Transl Sci |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley and Sons Inc.
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6853264/ https://ncbi.nlm.nih.gov/pubmed/31297924 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cts.12667 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|